Appointment of Dr Karl Keegan

Cambridge, UK - 18th February 2020

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs today announces the appointment of Dr Karl Keegan to the Board of Nuformix as a Non-Executive Director with immediate effect.

Download News

Back to all News